These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38616172)

  • 1. Public preferences for pharmacogenetic testing in the NHS: Embedding a discrete choice experiment within service design to better meet user needs.
    McDermott JH; Sharma V; Newman WG; Wilson P; Payne K; Wright S
    Br J Clin Pharmacol; 2024 Jul; 90(7):1699-1710. PubMed ID: 38616172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment.
    Porteous T; Ryan M; Bond C; Watson M; Watson V
    PLoS One; 2016; 11(3):e0152257. PubMed ID: 27031588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
    Naik-Panvelkar P; Armour C; Rose JM; Saini B
    Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for healthcare delivery through community pharmacy settings in the USA: A discrete choice study.
    Feehan M; Walsh M; Godin J; Sundwall D; Munger MA
    J Clin Pharm Ther; 2017 Dec; 42(6):738-749. PubMed ID: 28627110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for managing symptoms of differing severity: a discrete choice experiment.
    Rennie L; Porteous T; Ryan M
    Value Health; 2012 Dec; 15(8):1069-76. PubMed ID: 23244809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritising health service innovation investments using public preferences: a discrete choice experiment.
    Erdem S; Thompson C
    BMC Health Serv Res; 2014 Aug; 14():360. PubMed ID: 25167926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey on awareness, knowledge and preferences toward genetic testing among the United States general public.
    Fahim SM; Westrick SC; Qian J; Ngorsuraches S; Watts Alexander CS; Lloyd KB; Hohmann NS
    Per Med; 2024; 21(2):117-129. PubMed ID: 38380527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.
    Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X
    BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results.
    Haga SB; Kawamoto K; Agans R; Ginsburg GS
    Genet Med; 2011 Oct; 13(10):887-90. PubMed ID: 21673581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences for stratified medicine in psoriasis: a discrete choice experiment.
    Dalal G; Wright SJ; Vass CM; Davison NJ; Vander Stichele G; Smith CH; Griffiths CEM; Payne K;
    Br J Dermatol; 2021 Nov; 185(5):978-987. PubMed ID: 33991338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Preference Heterogeneity and Predicted Uptake Rate of Upper Gastrointestinal Cancer Screening Programs in Rural China: Discrete Choice Experiments and Latent Class Analysis.
    Liu R; Li Q; Li Y; Wei W; Ma S; Wang J; Zhang N
    JMIR Public Health Surveill; 2023 Jul; 9():e42898. PubMed ID: 37428530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment.
    Gerard K; Tinelli M; Latter S; Smith A; Blenkinsopp A
    Health Expect; 2015 Dec; 18(6):2223-35. PubMed ID: 24720861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Australian public's preferences for emergency care alternatives and the influence of the presenting context: a discrete choice experiment.
    Harris P; Whitty JA; Kendall E; Ratcliffe J; Wilson A; Littlejohns P; Scuffham PA
    BMJ Open; 2015 Apr; 5(4):e006820. PubMed ID: 25841233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public Preferences for Digital Health Data Sharing: Discrete Choice Experiment Study in 12 European Countries.
    Biasiotto R; Viberg Johansson J; Alemu MB; Romano V; Bentzen HB; Kaye J; Ancillotti M; Blom JMC; Chassang G; Hallinan D; Jónsdóttir GA; Monasterio Astobiza A; Rial-Sebbag E; Rodríguez-Arias D; Shah N; Skovgaard L; Staunton C; Tschigg K; Veldwijk J; Mascalzoni D
    J Med Internet Res; 2023 Nov; 25():e47066. PubMed ID: 37995125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preference of primary care patients for home-based healthcare and support services: a discrete choice experiment in China.
    Liu Y; Du S; Liu C; Xue T; Tang Y
    Front Public Health; 2024; 12():1324776. PubMed ID: 38699415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences and willingness-to-pay for community pharmacy-led Medicare Part D consultation services: A discrete choice experiment.
    Murry LT; Viyurri B; Chapman CG; Witry MJ; Kennelty KA; Nayakankuppam D; Doucette WR; Urmie J
    Res Social Adm Pharm; 2023 May; 19(5):764-772. PubMed ID: 36710174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study.
    Regier DA; Veenstra DL; Basu A; Carlson JJ
    Pharmacoeconomics; 2020 Jan; 38(1):57-68. PubMed ID: 31489595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public preferences and willingness to pay for a net zero NHS: a protocol for a discrete choice experiment in England and Scotland.
    Loría-Rebolledo LE; Abbott M; Antunes M; Norwood P; Ryan M; Watson V; Wu H
    BMJ Open; 2024 Jun; 14(6):e082863. PubMed ID: 38908844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery.
    Powell G; Holmes EA; Plumpton CO; Ring A; Baker GA; Jacoby A; Pirmohamed M; Marson AG; Hughes DA
    Br J Clin Pharmacol; 2015 Nov; 80(5):1149-59. PubMed ID: 26138622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.